Seres Therapeutics, Inc. (MCRB) Analyst Forecast

$0.92

south_east -$0.04 (-3.75%)
Day's range
$0.92
Day's range
$0.97

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
06/07/2024 Chardan Capital Keay Nakae $1.25 $0.85   46.52%

Seres Therapeutics, Inc. FAQ's

What analysts cover Seres Therapeutics, Inc.?

Seres Therapeutics, Inc. has been rated by research analysts at Chardan Capital in the past 90 days.